SQUAREX
Squarex is a clinical-stage pharmaceutical company developing a drug and topical application to prevent infections. This application develops a topical formulation of the immunomodulator squaric acid dibutyl ester for the prevention of recurrent cold sores and other infections caused by Herpes Simplex Virus 1 or Herpes Simplex Virus 2. The company was founded in 2012 and is headquartered in Saint Paul, Minnesota.
SQUAREX
Industry:
Health Care Medical Pharmaceutical Wellness
Founded:
2012-01-01
Address:
Saint Paul, Minnesota, United States
Country:
United States
Website Url:
http://www.squarex-pharma.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Euro Cloudflare Hosting
Similar Organizations
Abfero Pharmaceuticals
Abfero Pharmaceuticals is a clinical stage pharmaceutical company that specializes in healthcare and medical industry.
Aerie Pharmaceuticals
Aerie Pharmaceuticals is a clinical-stage pharmaceutical company developing products for the treatment of glaucoma.
AEROGEN PHARMA
AEROGEN PHARMA is a clinical-stage specialty pharmaceutical company developing proprietary inhaled medications.
Affinivax
Affinivax is a biopharmaceutical company developing vaccines that target infectious diseases.
Karyopharm Therapeutics
Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for the treatment of cancer and other major diseases.
Metacrine
Metacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs.
Perosphere
Perosphere is a private specialty pharmaceutical company developing rescue medications.
Current Employees Featured
Founder
Official Site Inspections
http://www.squarex-pharma.com
- Host name: 35.0.153.160.host.secureserver.net
- IP address: 160.153.0.35
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Squarex"
Improving immune system to prevent cold sores. - Squarex
The reflected in our forward-looking statements may not be achieved could differ materially from those projected in the forward-looking required by applicable law, SquareX Pharmaceuticals …See details»
SquareX Pharmaceutical Corporation - LinkedIn
SquareX Pharmaceutical Corporation Pharmaceutical Manufacturing St Paul, Minnesota 128 followers We are developing a drug (topical immune stimulator) that prevents oral herpes or …See details»
Squarex 2025 Company Profile: Valuation, Funding
Squarex Pharmaceutical Corp is a pharmaceutical company developing a late …See details»
Squarex - Crunchbase Company Profile & Funding
Squarex is a clinical-stage pharmaceutical company developing a drug and topical application to prevent infections.See details»
Squarex Pharmaceutical - Products, Competitors, Financials, …
About Squarex Pharmaceutical Squarex Pharmaceutical is a clinical stage company focused on the development of pharmaceutical solutions for the prevention of cold sores, operating within …See details»
Squarex, LLC - P2PMarketData Company Profile
Saint Paul, United States of America Legal Name:Squarex, LLC Company ID:45-5576357 Year Founded:2012 Industry:Pharmaceuticals Website: https://Squarex-pharma.com SEC FilingsSee details»
SEC.gov
“Squarex” in this prospectus mean Squarex Pharmaceutical Corporation, a Delaware corporation. Our Company We are a late-clinical-stage pharmaceutical company developing a drug that is …See details»
Squarex Announces End of Phase 2 Meeting with FDA …
Saint Paul, Minnesota, USA, 19 January 2021 – Squarex Pharma (SQX), a St. Paul, Minnesota, USA-based company, announced updated results from its …See details»
Cold sore prevention biotech Squarex withdraws $15 …
May 19, 2023 Squarex Pharmaceutical, a Phase 2 biotech developing a topical therapy for cold sores, withdrew its plans for an initial public offering on Friday. …See details»
St. Paul-based Squarex Withdraws IPO Plans - Twin …
May 22, 2023 A St. Paul biotech company run by one-time gubernatorial candidate Hugh McTavish has shelved plans to go public, for now. On Friday, …See details»
SQUAREX LLC Company Profile | Saint Paul, MN - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for SQUAREX LLC of Saint Paul, MN. Get the latest business insights from Dun & Bradstreet.See details»
Squarex’s Competitors, Revenue, Number of Employees, Funding …
Squarex’s Profile, Revenue and Employees. Squarex is a Minnesota-based clinical-stage pharmaceutical company that develops immunomodulator squaric acid dibutyl esters for the …See details»
Squarex Pharmaceutical Corp. - IPOScoop
Squarex Pharmaceutical Corp. | IPOScoopSquarex Pharmaceutical Corp.See details»
SQUAREX PHARMACEUTICAL CORPORATION 03-24-2023 Form S …
The information contained in this Memorandum was obtained from Squarex Pharmaceutical Corporation (the “Company”) and from other sources. Any estimates, projections or other …See details»
Sample - Squarex
Better than Valtrex®, a $ billion drug Prevents outbreaks instead of just shortening them Reduces severity More convenient dosing--any time vs. only in the first 24 hours. One dose lasts 3 …See details»
SquareX Pharmaceutical Corporation Overview - SignalHire
SquareX Pharmaceutical Corporation headquarters is in St Paul, Minnesota. SquareX Pharmaceutical Corporation is in the sectors of: Pharma. To connect with SquareX …See details»
Squarex Pharma Signs Investment Term Sheet for Up to $75
Dec 7, 2021 Squarex, LLC, announced today that it has signed a term sheet to go public with a notable health-care-focused institutional investor. The terms of the dealSee details»
SciMed Biotech Podcast with Hugh McTavish of SquareX …
Sep 19, 2024 In this episode of the SciMed Biotech Podcast, we sit down with Hugh McTavish, a man whose personal and professional life exemplifies the power of resilience. As the founder …See details»
Squarex LLC Overview - Salary.com
Discover essential details about Squarex LLC, including address, contact, and journey of our company's evolution.See details»
Squarex Announces End of Phase 2 Meeting with FDA for its Cold …
Squarex Announces End of Phase 2 Meeting with FDA for its Cold Sore Prevention Asset Squarex Pharma announced updated results from its successful Phase 2 clinical study on …See details»